약물과민반응 환자에서 탈감작요법 적용

키워드

참고문헌 (79)

1. Mezzano V, "Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy", BioDrugs, 28, pp.133~144 (2014)
2. Ring J, "100 years of hyposensitization : history of allergen-specific immunotherapy(ASIT)", Allergy, 66, pp.713~724 (2011)
3. Widal MF, "Anaphylaxie et idiosyncraise", Presse Med, 30, pp.189~193 (1922)
4. O’Donovan WJ, "Sensitivity to penicillin; anaphylaxis and desensitisation", Lancet, 2, pp.444~446 (1946)
5. Vultaggio A, "Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction", J Allergy Clin Immunol Pract, 8, pp.1764~1767 (2020)
6. Ang WX, "Mast cell desensitization inhibits calcium flux and aberrantly remodels actin", J Clin Invest, 126, pp.4103~4118 (2016)
7. Sancho-Serra Mdel C, "Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalization", Eur J Immunol, 41, pp.1004~1013 (2011)
8. Mahajan A, "Optimal aggregation of FcεRI with a structurally defined trivalent ligand overrides negative regulation driven by phosphatases", ACS Chem Biol, 9, pp.1508~1519 (2014)
9. Shalit M, "Challenge of mast cells with increasing amounts of antigen induces desensitization", Clin Exp Allergy, 25, pp.896~902 (1995)
10. Andrews NL, "Small, mobile FcepsilonRI receptor aggregates are signaling competent", Immunity, 31, pp.469~479 (2009)
11. Oka T, "Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells", J Allergy Clin Immunol, 132, pp.922~932 (2013)
12. Paolini R, "Phosphorylation", dephosphorylation of high-affinity IgE receptors : a mechanism for coupling, Proc Natl Acad Sci U S A, pp.1992, 89[DOI]
13. Macglashan D, "Loss of syk kinase during IgE-mediated stimulation of human basophils", J Allergy Clin Immunol, 114, pp.1317~1324 (2004)
14. Katz HR, "Inhibitory receptors and allergy", Curr Opin Immunol, 14, pp.698~704 (2002)
15. Lu-Kuo JM, "gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization", J Biol Chem, 274, pp.5791~5796 (1999)
16. Pichler WJ, "Anaphylaxis to drugs : overcoming mast cell unresponsiveness by fake antigens", Allergy, 76, pp.1340~1349 (2021)
17. Naclerio R, "Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin", J Allergy Clin Immunol, 71, pp.294~301 (1983)
18. Shamji MH, "Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses : novel biomarker of subcutaneous grass pollen immunotherapy", J Allergy Clin Immunol, 143, pp.1067~1076 (2019)
19. Vultaggio A, "Mechanisms of drug desensitization : not only mast cells", Front Pharmacol, 11, pp.590991~ (2020)
20. Teraki Y, "Successful desensitization to fixed drug eruption : the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization", Dermatology, 209, pp.29~32 (2004)
21. Aydogan M, "Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome : increase in number of Treg cells after desensitization", J Allergy Clin Immunol, 132, pp.478~480 (2013)
22. Tuzer C, "Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels", Allergy, 75, pp.2942~2945 (2020)
23. 이애라, "일차 항결핵제 모두에 과민반응을 보인 환자의 성공적 탈감작 결핵 치료 1예", Allergy Asthma & Respiratory Disease, 1(4), pp.395~399 (2013), 대한 소아알레르기 호흡기학회
24. 윤도란, "Trimethoprim-sulfamethoxazole에 대해 지연성 과민반응을 보인 환자에서 성공적인 급속 탈감작 치료 사례 1예", Allergy Asthma & Respiratory Disease, 3(2), pp.155~158 (2015), 대한 소아알레르기 호흡기학회
25. 허연정, "Fluconazole 지연형 과민반응에 대한 성공적인 탈감작 사례 1예", Allergy Asthma & Respiratory Disease, 6(1), pp.68~71 (2018), 대한 소아알레르기 호흡기학회[DOI]
26. David In-Chull Hong, "Desensitization for Allergic Reactions to Chemotherapy", Yonsei Medical Journal, 60(2), pp.119~125 (2019), 연세대학교의과대학[DOI]
27. Castells MC, "Hypersensitivity reactions to chemotherapy : outcomes and safety of rapid desensitization in 413 cases", J Allergy Clin Immunol, 122, pp.574~580 (2008)
28. Alvarez-Cuesta E, "Standards for practical intravenous rapid drug desensitization & delabeling : a WAO committee statement", World Allergy Organ J, 15, pp.100640~ (2022)
29. Breslow RG, "Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization", Ann Allergy Asthma Immunol, 102, pp.155~160 (2009)
30. Caiado J, "Drug desensitizations for chemotherapy : safety and efficacy in preventing anaphylaxis", Curr Allergy Asthma Rep, 21, pp.37~ (2021)
31. 서장호, "점진적 단계 단축을 적용한 cetuximab 탈감작요법 사례 1예", Allergy Asthma & Respiratory Disease, 10(3), pp.181~185 (2022), 대한 소아알레르기 호흡기학회[DOI]
32. 정재우, "항암제 과민반응에 대한 탈감작요법", Allergy Asthma & Respiratory Disease, 8(3), pp.105~106 (2020), 대한 소아알레르기 호흡기학회[DOI]
33. Sloane D, "Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies", J Allergy Clin Immunol Pract, 4, pp.497~504 (2016)
34. Markman M, "Paclitaxel-associated hypersensitivity reactions : experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center", J Clin Oncol, 18, pp.102~105 (2000)
35. Lee CW, "Rapid inpatient", outpatient desensitization for chemotherapy hypersensitivity : standard protocol effective in 57 patients for 255 courses, 2005, pp.99, 393~399
36. Markman M, "Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity", J Clin Oncol, 21, pp.4611~4614 (2003)
37. Lee EY, "Interleukin-6 and cytokine release syndrome : a new understanding in drug hypersensitivity reactions", Ann Allergy Asthma Immunol, 130, pp.178~184 (2023)
38. 이서영, "항암제 과민반응에 대한 탈감작요법의 최신지견", Allergy Asthma & Respiratory Disease, 1(4), pp.295~302 (2013), 대한 소아알레르기 호흡기학회
39. Essayan DM, "Successful parenteral desensitization to paclitaxel", J Allergy Clin Immunol, 97, pp.42~46 (1996)
40. Tsao LR, "Hypersensitivity reactions to platinum agents and taxanes", Clin Rev Allergy Immunol, 62, pp.432~448 (2022)
41. 이은정, "Rituximab 주입관련 부작용발생 및 위험인자 분석", 한국임상약학회지, 23(3), pp.223~231 (2013), 한국임상약학회
42. Joo MH, "Risk factors of infusion related reaction to rituximab in patients with lymphoma", JPERM, 10, pp.60~67 (2018)
43. Jung JW, "The incidence and risk factors of infusion related reactions to rituximab for treating B cell malignancy in a single tertiary hospital", Oncology, 86, pp.127~134 (2014)
44. Lee CW, "Carboplatin hypersensitivity : a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell", IgE-mediated reactions, 2004, pp.95, 370~376
45. Lee JH, "A one-bag rapid desensitization protocol for paclitaxel hypersensitivity : a noninferior alternative to a multi-bag rapid desensitization protocol", J Allergy Clin Immunol Pract, 8, pp.696~703 (2020)
46. 이수호, "Rituximab 지연성과민반응에 대한 신속 탈감작 적용 1예", Allergy Asthma & Respiratory Disease, 7(2), pp.109~112 (2019), 대한 소아알레르기 호흡기학회
47. Shin YS, "Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers", Pharmacoepidemiol Drug Saf, 18, pp.910~915 (2009)
48. Kim HH, "Analysis of breakthrough reactions in 1, 143 desensitization procedures in a single tertiary hospital using a one-bag desensitization protocol", Front Allergy, 3, pp.786822~ (2022)
49. Shin YS, "Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers", Pharmacoepidemiol Drug Saf, 18, pp.910~915 (2009)
50. Park HK, "Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea", Allergol Int, 66, pp.557~562 (2017)
51. Romano A, "Towards a more precise diagnosis of hypersensitivity to beta-lactams-an EAACI position paper", Allergy, 75, pp.1300~1315 (2020)
52. Mayorga C, "In vitro tests for drug hypersensitivity reactions : an ENDA", EAACI Drug Allergy Interest Group position paper, 2016, pp.71, 1103~1134
53. Cernadas JR, "General considerations on rapid desensitization for drug hypersensitivity-a consensus statement", Allergy, 65, pp.1357~1366 (2010)
54. Chastain DB, "Antimicrobial desensitization: a review of published protocols", Pharmacy(Basel), 7, pp.112~ (2019)
55. Lin RY, "Desensitization in the management of vancomycin hypersensitivity", Arch Intern Med, 150, pp.2197~2198 (1990)
56. Shadur B, "Desensitisation to liposomal amphotericin B", J Allergy Clin Immunol Pract, 5, pp.181~183 (2017)
57. Randolph C, "Rapid desensitization to fluconazole(Diflucan)", Ann Allergy Asthma Immunol, 100, pp.616~617 (2008)
58. Jean T, "Successful desensitization of voriconazole in an immunosuppressed pediatric patient", J Allergy Clin Immunol Pract, 3, pp.637~638 (2015)
59. Seki JT, "Recurrent body rash warranted second desensitization with acyclovir in a myeloma patient : a case report", J Clin Med Res, 9, pp.725~728 (2017)
60. Gonzalez-Estrada A, "Novel valganciclovir desensitization protocol", Transplantation, 98, pp.50~51 (2014)
61. Ladd AM, "Successful desensitization to ribavirin in a patient with chronic hepatitis C", J Clin Gastroenterol, 46, pp.716~717 (2012)
62. 박재석, "결핵의 치료지침", 대한내과학회지, 82(3), pp.269~273 (2012), 대한내과학회
63. 김현화, "1차 항결핵제 약물이상반응 현황: 단일기관 약물이상사례 보고사례 기반 분석", 대한내과학회지, 96(5), pp.421~431 (2021), 대한내과학회[DOI]
64. Kobashi Y, "Desensitization therapy for allergic reactions to antituberculous drugs", Intern Med, 49, pp.2297~2301 (2010)
65. 문성도, "이차 항결핵제에 약물과민반응증후군을 보인 다제내성 결핵 환자에서 급속 탈감작요법에 준한 항결핵제 재투여 1예", Allergy Asthma & Respiratory Disease, 3(4), pp.297~301 (2015), 대한 소아알레르기 호흡기학회[DOI]
66. Oh JH, "Reintroduction of antituberculous drugs in patients with antituberculous drug-related drug reaction with eosinophilia and systemic symptoms", J Allergy Clin Immunol Pract, 9, pp.3442~3449 (2021)
67. Holland CL, "Rapid oral desensitization to isoniazid and rifampin", Chest, 98, pp.1518~1519 (1990)
68. Kim JH, "Rapid oral desensitization to isoniazid, rifampin, and ethambutol", Allergy, 58, pp.540~541 (2003)
69. 이서영, "Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs", Allergy, Asthma & Immunology Research, 11(2), pp.212~221 (2019), 대한천식알레르기학회
70. Mastalerz L, "Mechanism of chronic urticaria exacerbation by aspirin", Curr Allergy Asthma Rep, 5, pp.277~283 (2005)
71. Wan Yin Winnie Yeung, "Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity", Yonsei Medical Journal, 61(1), pp.4~14 (2020), 연세대학교의과대학[DOI]
72. Cortellini G, "Aspirin challenge and desensitization : how, when and why", Curr Opin Allergy Clin Immunol, 17, pp.247~254 (2017)
73. Lee TH, "Leukotrienes and aspirin induced asthma", Thorax, 48, pp.1189~1190 (1993)
74. Canto MG, "Selective immediate hypersensitivity reactions to NSAIDs", Curr Opin Allergy Clin Immunol, 9, pp.293~297 (2009)
75. Wohrl S, "NSAID hypersensitivity-recommendations for diagnostic work up and patient management", Allergo J Int, 27, pp.114~121 (2018)
76. Sanchez Borges M, "Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions", Ann Allergy Asthma Immunol, 87, pp.201~204 (2001)
77. Cortellini G, "Effective ibuprofen desensitization in a patient with myopericarditis", Pharmacology, 103, pp.111~113 (2019)
78. Bianco S, "Aspirin induced tolerance in aspirin-asthma detected by a new challenge test", J Med Sci, 5, pp.129~130 (1977)
79. Zeiss CR, "Refractory period to aspirin in a patient with aspirin-induced asthma", J Allergy Clin Immunol, 57, pp.440~448 (1976)

관련 논문AI추천